Inosine Research Study in Parkinson’s Disease
PARKINSON’S DISEASE DRUG STUDY
We are conducting a multicenter randomized clinical trial to evaluate the safety and effectiveness of Inosine in slowing the progression of Parkinson’s Disease.
If you have any of the following:
• Tremors or shaking
• Slowed movements
• Small handwriting
• Poor balance or problems walking
All of these may be symptoms of Parkinson’s disease.
You may qualify for this PD drug study if you:
• Have a diagnosis of Parkinson’s within the last 3 years or if you are experiencing some of the above symptoms
• Not on any PD medications other than rasagiline (Azilect) or selegiline (Deprynl)
• Do not have a history of gout or kidney stones
Eligible participants will receive study-related evaluations, laboratory tests, and the investigational drug at no cost. For more information about this study, please contact:Boston University Medical Center Parkinson’s Disease and Movement Disorder Center at 617-638-7737 or 617-638-7745
IRB # H-28452